ISOThrive has exclusively licensed two U.S. patents from Louisiana State University:

“Isomaltooligosaccharides from Leuconostoc as neutraceuticals”
U.S. Patent No. 7,291,607, issued November 6, 2007.  View Patent »
“Isomaltooligosaccharides to inhibit avian pathogenic intestinal bacteria”
U.S. Patent No. 7,772,212, issued August 10, 2010.   View Patent »

ISOThrive has multiple additional patents pending worldwide.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.